T&R Biofab Co

T&R Biofab Co EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of T&R Biofab Co (246710.KQ) as of Oct 20, 2026 is -9.24 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was -8.91 % — a change of 3.80% (lower).

EBIT/Assets

-9.24 %

YoY

3.80%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of T&R Biofab Co is 2025 -9.24 % . Operating Income to Assets Ratio (EBIT/Assets) of T&R Biofab Co was 2024 -8.91 % . It decreases by 3.80% lower compared to the previous year.

The T&R Biofab Co EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2018
-15.86 KRW
Jan 1, 2019
-25.32 KRW
Jan 1, 2020
-11.36 KRW
Jan 1, 2021
-12.99 KRW
Jan 1, 2022
-10.59 KRW
Jan 1, 2023
-13.57 KRW
Jan 1, 2024
-8.91 KRW
Jan 1, 2025
-9.24 KRW
The T&R Biofab Co EBIT/Assets history
YEAREBIT/AssetsYoY
-9.24 %+3.80%
-8.91 %-34.36%
-13.57 %+28.11%
-10.59 %-18.44%
-12.99 %+14.33%
-11.36 %-55.15%
-25.32 %+59.64%
-15.86 %-63.89%
-43.94 %+35.88%
-32.33 %+58.41%
-20.41 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

T&R Biofab Co Stock analysis

What does T&R Biofab Co do? T&R Biofab Co Ltd, based in Siheung, South Korea, operates in the Health Care sector, manufacturing and selling biomedical equipment. The company, listed on 28 November 2018, produces bioresorbable scaffolds under the T&R Mesh and T&R Dental Mesh brands, as well as 3D biodegradable polymer printing systems, bioinks (deCelluid), and 3D organoid and cell therapies. It serves domestic and international markets with its innovative medical solutions. T&R Biofab Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about T&R Biofab Co stock

Operating Income to Assets Ratio (EBIT/Assets) of T&R Biofab Co is -9.24 % in 2025.

Operating Income to Assets Ratio (EBIT/Assets) of T&R Biofab Co changed from -8.91 % to -9.24 %, representing a 3.80% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) T&R Biofab Co since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s T&R Biofab Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — T&R Biofab Co

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — T&R Biofab Co